Displaying 51 - 100 of 170 results
Released Company Title Industry Topic
23 Nov 2023
06:58 CET
GIMV Strong results confirm strategy of value creation through growth 30202010 Asset Managers and Custodians Other subject
23 Nov 2023
06:58 CET
GIMV Strong results confirm strategy of value creation through growth 30202010 Asset Managers and Custodians Other subject
23 Dec 2022
07:45 CET
GIMV Gimv investiert in die Energietransformation und kritische Infrastruktur in Deutschland und schließt Partnerschaft mit Rohrleitungsbau Münster 30202010 Asset Managers and Custodians Other subject
23 Dec 2022
07:45 CET
GIMV Gimv invests in the energy transition and critical infrastructure in Germany and announces a partnership with Rohrleitungsbau Münster 30202010 Asset Managers and Custodians Other subject
23 Dec 2022
07:45 CET
GIMV Gimv zet in op energietransitie en kritieke infrastructuur in Duitsland en kondigt partnership met Rohrleitungsbau Münster aan 30202010 Asset Managers and Custodians Other subject
09 Dec 2022
07:30 CET
GIMV Gimv verkoopt Biolam aan het management geruggesteund door investeerders na een snel en succesvol groeitraject tot een toonaangevende Franse groep van klinische testlaboratoria 30202010 Asset Managers and Custodians Other subject
09 Dec 2022
07:30 CET
GIMV Gimv exits Biolam to its management backed by investors after a fast and successful growth trajectory into a leading French group of clinical testing labs 30202010 Asset Managers and Custodians Other subject
09 Dec 2022
07:30 CET
GIMV Gimv cède sa participation dans Biolam, devenu un acteur majeur dans le domaine de la biologie médicale après une trajectoire de croissance rapide et réussie 30202010 Asset Managers and Custodians Other subject
17 Nov 2022
06:58 CET
GIMV Une croissance maintenue en période difficile 30202010 Asset Managers and Custodians Other subject
17 Nov 2022
06:58 CET
GIMV Aangehouden groei in moeilijke tijden 30202010 Asset Managers and Custodians Other subject
17 Nov 2022
06:58 CET
GIMV Anhaltendes Wachstum in schwierigen Zeiten 30202010 Asset Managers and Custodians Other subject
17 Nov 2022
06:58 CET
GIMV Sustained growth in difficult times 30202010 Asset Managers and Custodians Other subject
21 Sep 2022
07:30 CEST
GIMV Gimv partners with the founders of Les Psy Réunis group to develop a leading outpatient mental care provider in Switzerland 30202010 Asset Managers and Custodians Other subject
21 Sep 2022
07:30 CEST
GIMV Gimv werkt samen met de oprichters van de groep Les Psy Réunis om een leider in de ambulante geestelijke gezondheidszorg in Zwitserland uit te bouwen. 30202010 Asset Managers and Custodians Other subject
21 Sep 2022
07:30 CEST
GIMV Gimv s’associe aux fondateurs du groupe Les Psy Réunis afin d’accompagner le développement d’un leader des soins mentaux en Suisse 30202010 Asset Managers and Custodians Other subject
27 Jul 2022
17:45 CEST
GIMV Outcome of the optional dividend for the financial year 2021/2022: 53.3% of the dividend rights on the financial year 2021/2022 are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 25.9 million 30202010 Asset Managers and Custodians Other subject
27 Jul 2022
17:45 CEST
GIMV Résultat du dividende optionnel pour l\'exercice 2021/2022: 53,3% des droits au dividende pour l’exercice 2021/2022 ont été distribués sous la forme de nouvelles actions ordinaires, résultant en une augmentation de capital de 25,9 millions d’euro 30202010 Asset Managers and Custodians Other subject
27 Jul 2022
17:45 CEST
GIMV Resultaat van het keuzedividend over het boekjaar 2021/2022: 53,3% van de dividendrechten over het boekjaar 2021/2022 worden uitgekeerd onder de vorm van nieuwe gewone aandelen, wat leidt tot een kapitaalverhoging van 25,9 miljoen EUR 30202010 Asset Managers and Custodians Other subject
13 Jul 2022
07:30 CEST
GIMV Gimv draagt belang in de Eurocept-groep - actief in 30202010 Asset Managers and Custodians Other subject
13 Jul 2022
07:30 CEST
GIMV Gimv transfers stake in the Eurocept group - active in 30202010 Asset Managers and Custodians Other subject
13 Jul 2022
07:30 CEST
GIMV Gimv transfers stake in the Eurocept group - active in 30202010 Asset Managers and Custodians Other subject
13 Jul 2022
07:30 CEST
GIMV Gimv transfers stake in the Eurocept group - active in 30202010 Asset Managers and Custodians Other subject
12 Jul 2022
07:30 CEST
GIMV Gimv, Lenaerts/LVR and ABN Climatization lay the foundation of a leading group of installation companies 30202010 Asset Managers and Custodians Other subject
12 Jul 2022
07:30 CEST
GIMV Gimv, Lenaerts/LVR en ABN Klimatisatie leggen de eerste steen voor uitbouw van een toonaangevende groep van installatiebedrijven 30202010 Asset Managers and Custodians Other subject
12 Jul 2022
07:30 CEST
GIMV Gimv, Lenaerts/LVR and ABN Climatization lay the foundation of a leading group of installation companies 30202010 Asset Managers and Custodians Other subject
12 Jul 2022
07:30 CEST
GIMV Gimv, Lenaerts/LVR and ABN Climatization lay the foundation of a leading group of installation companies 30202010 Asset Managers and Custodians Other subject
29 Jun 2022
17:45 CEST
GIMV Verslag van de gewone algemene vergadering van aandeelhouders: Goedkeuring van een brutodividend van 2,60 EUR per aandeel in de vorm van een keuzedividend 30202010 Asset Managers and Custodians Other subject
29 Jun 2022
17:45 CEST
GIMV Report of the Annual and Special General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.60 per share in the form of an optional dividend 30202010 Asset Managers and Custodians Other subject
29 Jun 2022
17:45 CEST
GIMV Report of the Annual and Special General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.60 per share in the form of an optional dividend 30202010 Asset Managers and Custodians Other subject
29 Jun 2022
07:30 CEST
GIMV Gimv – Modaliteiten van het keuzedividend Inbreng van het nettodividend voor inschrijving op één nieuw aandeel tegen 45,50 EUR, zijnde 25 dividendrechten over het boekjaar 2021/2022 30202010 Asset Managers and Custodians Other subject
29 Jun 2022
07:30 CEST
GIMV Gimv - Modalités du dividende optionnel Apport du droit au dividende net en échange de la souscription d\'une nouvelle action à 45,50 euros ou 25 droits au dividende relatifs à l’exercice 2021/2022 30202010 Asset Managers and Custodians Other subject
29 Jun 2022
07:30 CEST
GIMV Gimv - Modalités du dividende optionnel Apport du droit au dividende net en échange de la souscription d\'une nouvelle action à 45,50 euros ou 25 droits au dividende relatifs à l’exercice 2021/2022 30202010 Asset Managers and Custodians Other subject
15 Jun 2022
07:30 CEST
GIMV Gimv strengthens its position in life sciences venture capital with the creation of a new dedicated platform 30202010 Asset Managers and Custodians Other subject
15 Jun 2022
07:30 CEST
GIMV Gimv strengthens its position in life sciences venture capital with the creation of a new dedicated platform 30202010 Asset Managers and Custodians Other subject
15 Jun 2022
07:30 CEST
GIMV Gimv versterkt zijn positie in life sciences met de oprichting van een nieuw investeringsplatform 30202010 Asset Managers and Custodians Other subject
09 Jun 2022
07:30 CEST
GIMV Gimv neemt een significant belang in Picot, een industriële groep actief in de productie van poort- & hekwerk en aanbieder van omheiningsoplossingen. 30202010 Asset Managers and Custodians Other subject
09 Jun 2022
07:30 CEST
GIMV Gimv prend une participation significative dans Picot, groupe industriel spécialisé dans les portails, les clôtures et la gestion des accès 30202010 Asset Managers and Custodians Other subject
09 Jun 2022
07:30 CEST
GIMV Gimv takes a significant interest in Picot, an industrial group active in the production of gates & fencing and provider of fencing solutions 30202010 Asset Managers and Custodians Other subject
07 Jun 2022
07:30 CEST
GIMV Gimv co-leads CHF 71M (USD 74M) Series B financing in ImmunOs Therapeutics to develop novel therapies in oncology and autoimmune disease. 30202010 Asset Managers and Custodians Other subject
07 Jun 2022
07:30 CEST
GIMV Gimv co-leads CHF 71M (USD 74M) Series B financing in ImmunOs Therapeutics to develop novel therapies in oncology and autoimmune disease. 30202010 Asset Managers and Custodians Other subject
07 Jun 2022
07:30 CEST
GIMV Gimv leidt CHF 71 miljoen (USD 74 miljoen) Series B-financiering in ImmunOs Therapeutics voor de ontwikkeling van nieuwe therapieën in oncologie en auto-immuunziekten. 30202010 Asset Managers and Custodians Other subject
25 May 2022
17:00 CEST
GIMV Convocation of the annual general meeting of Gimv on June 29th, 2022 30202010 Asset Managers and Custodians Other subject
25 May 2022
17:00 CEST
GIMV Convocation of the annual general meeting of Gimv on June 29th, 2022 30202010 Asset Managers and Custodians Other subject
25 May 2022
17:00 CEST
GIMV Oproeping van de gewone algemene vergadering van Gimv op 29 juni 2022 30202010 Asset Managers and Custodians Other subject
24 May 2022
07:30 CEST
GIMV Gimv investeert verder in industriële automatisering en verwerft een meerderheidsbelang in Variotech, leverancier van aangepaste werkstukdragers voor geautomatiseerde productieprocessen. 30202010 Asset Managers and Custodians Other subject
24 May 2022
07:30 CEST
GIMV Gimv further invests in industrial automation and becomes majority owner of workpiece carrier specialist Variotech 30202010 Asset Managers and Custodians Other subject
24 May 2022
07:30 CEST
GIMV Gimv investiert erneut in Industrieautomatisierung und wird Mehrheitseigner des Werkstückträgerspezialisten Variotech 30202010 Asset Managers and Custodians Other subject
24 May 2022
07:30 CEST
GIMV Gimv further invests in industrial automation and becomes majority owner of workpiece carrier specialist Variotech 30202010 Asset Managers and Custodians Other subject
19 May 2022
06:58 CEST
GIMV Résultat solide grâce l’excellente performance des entreprises du portefeuille 30202010 Asset Managers and Custodians Other subject
19 May 2022
06:58 CEST
GIMV Indrukwekkende groeiprestaties bij onze bedrijven leiden tot een sterk resultaat 30202010 Asset Managers and Custodians Other subject